CS257791B2 - Method of eburnamenine's racemic and optically active derivatives' transstereoisomers production - Google Patents

Method of eburnamenine's racemic and optically active derivatives' transstereoisomers production Download PDF

Info

Publication number
CS257791B2
CS257791B2 CS862862A CS286286A CS257791B2 CS 257791 B2 CS257791 B2 CS 257791B2 CS 862862 A CS862862 A CS 862862A CS 286286 A CS286286 A CS 286286A CS 257791 B2 CS257791 B2 CS 257791B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
filtered
dihydro
compounds
chloroform
Prior art date
Application number
CS862862A
Other languages
Czech (cs)
English (en)
Inventor
Janos Kreidl
Gyoergy Visky
Laszlo Czibula
Bela Stefko
Maria Farkas
Zsolt Szombathelyi
Egon Karpati
Bela Kiss
Katalin Csomor
Laszlo Szporny
Lilla Forgacs
Csaba Kuthi
Aniko Gere
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of CS257791B2 publication Critical patent/CS257791B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CS862862A 1985-04-19 1986-04-18 Method of eburnamenine's racemic and optically active derivatives' transstereoisomers production CS257791B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU851516A HU198207B (en) 1985-04-19 1985-04-19 Process for production of derivatives of eburnamenin and medical compositions containing them

Publications (1)

Publication Number Publication Date
CS257791B2 true CS257791B2 (en) 1988-06-15

Family

ID=10954833

Family Applications (1)

Application Number Title Priority Date Filing Date
CS862862A CS257791B2 (en) 1985-04-19 1986-04-18 Method of eburnamenine's racemic and optically active derivatives' transstereoisomers production

Country Status (32)

Country Link
US (1) US4839362A (US06724976-20040420-M00002.png)
JP (1) JPS61249982A (US06724976-20040420-M00002.png)
KR (1) KR860008175A (US06724976-20040420-M00002.png)
CN (1) CN1017429B (US06724976-20040420-M00002.png)
AR (1) AR242386A1 (US06724976-20040420-M00002.png)
AU (1) AU585973B2 (US06724976-20040420-M00002.png)
BE (1) BE904619A (US06724976-20040420-M00002.png)
CA (1) CA1314286C (US06724976-20040420-M00002.png)
CH (1) CH670449A5 (US06724976-20040420-M00002.png)
CS (1) CS257791B2 (US06724976-20040420-M00002.png)
DD (1) DD244555A5 (US06724976-20040420-M00002.png)
DE (1) DE3613199A1 (US06724976-20040420-M00002.png)
DK (1) DK179886A (US06724976-20040420-M00002.png)
ES (1) ES8801259A1 (US06724976-20040420-M00002.png)
FI (1) FI84352C (US06724976-20040420-M00002.png)
FR (1) FR2580647B1 (US06724976-20040420-M00002.png)
GB (1) GB2174092B (US06724976-20040420-M00002.png)
GR (1) GR861026B (US06724976-20040420-M00002.png)
HU (1) HU198207B (US06724976-20040420-M00002.png)
IL (1) IL78534A0 (US06724976-20040420-M00002.png)
IN (1) IN163020B (US06724976-20040420-M00002.png)
IT (1) IT1189462B (US06724976-20040420-M00002.png)
NL (1) NL8600987A (US06724976-20040420-M00002.png)
NO (1) NO861538L (US06724976-20040420-M00002.png)
NZ (1) NZ215881A (US06724976-20040420-M00002.png)
PH (1) PH22427A (US06724976-20040420-M00002.png)
PL (1) PL149331B1 (US06724976-20040420-M00002.png)
PT (1) PT82423B (US06724976-20040420-M00002.png)
SE (1) SE462684B (US06724976-20040420-M00002.png)
SU (1) SU1443801A3 (US06724976-20040420-M00002.png)
YU (1) YU46003B (US06724976-20040420-M00002.png)
ZA (1) ZA862937B (US06724976-20040420-M00002.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623501B1 (fr) * 1987-11-19 1990-03-16 Roussel Uclaf Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035784A1 (en) * 1969-03-27 1970-12-24 Olivier Louisette Vincamine derivs with therapeutic propert- - ies
FR2211004A5 (US06724976-20040420-M00002.png) * 1972-12-15 1974-07-12 Synthelabo
FR2259612B1 (US06724976-20040420-M00002.png) * 1974-01-31 1977-09-09 Synthelabo
FR2285390A1 (fr) * 1974-09-19 1976-04-16 Synthelabo Nouvelle methode de preparation du desoxyvincaminate d'hydroxy-2 propyle
HU171163B (hu) * 1974-09-27 1977-11-28 Richter Gedeon Vegyeszet Sposob poluchenija proizvodnykh trans eburnamenina
FR2299033A2 (fr) * 1975-01-31 1976-08-27 Synthelabo Esters de
HU170888B (hu) * 1975-06-10 1977-09-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh, opticheski aktivnykh proizvodnykh eburnameninov
HU171663B (hu) * 1975-09-01 1978-02-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh 14-skobka-zamehhennogo metil-skobka zakryta-vinkana
DE2703920A1 (de) * 1976-02-05 1977-08-11 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
GB1572189A (en) * 1976-09-03 1980-07-23 Buzas Andre 14 - alkoxycarbonyl - 3,4 - dehydro - 14,15 - dihydro-14,16 - eburnamenine perchlorates and their use to prepare stereoisomers of dihydro apovincaminic acid esters
AU532001B2 (en) * 1978-11-20 1983-09-15 Sumitomo Chemical Company, Limited Polycyclic indole derivatives
HU186891B (en) * 1981-06-12 1985-10-28 Richter Gedeon Vegyeszet Process for producing esters of apovincaminic acid

Also Published As

Publication number Publication date
SE8601798D0 (sv) 1986-04-18
US4839362A (en) 1989-06-13
IT8620135A0 (it) 1986-04-18
FR2580647B1 (fr) 1990-04-20
GR861026B (en) 1986-08-11
YU46003B (sh) 1992-12-21
HUT40653A (en) 1987-01-28
NL8600987A (nl) 1986-11-17
PH22427A (en) 1988-09-12
AR242386A1 (es) 1993-03-31
DE3613199A1 (de) 1986-10-23
IT1189462B (it) 1988-02-04
IT8620135A1 (it) 1987-10-18
CH670449A5 (US06724976-20040420-M00002.png) 1989-06-15
CA1314286C (en) 1993-03-09
CN86102655A (zh) 1987-02-04
SE8601798L (sv) 1986-10-20
GB2174092B (en) 1989-10-25
CN1017429B (zh) 1992-07-15
AU585973B2 (en) 1989-06-29
NO861538L (no) 1986-10-20
PL149331B1 (en) 1990-02-28
IN163020B (US06724976-20040420-M00002.png) 1988-07-30
KR860008175A (ko) 1986-11-12
YU60386A (en) 1988-08-31
FI84352C (fi) 1991-11-25
FR2580647A1 (fr) 1986-10-24
DD244555A5 (de) 1987-04-08
ES554136A0 (es) 1987-12-16
DK179886D0 (da) 1986-04-18
FI861656A (fi) 1986-10-20
HU198207B (en) 1989-08-28
AU5638086A (en) 1986-10-23
IL78534A0 (en) 1986-08-31
SU1443801A3 (ru) 1988-12-07
DK179886A (da) 1986-10-20
ES8801259A1 (es) 1987-12-16
SE462684B (sv) 1990-08-13
JPS61249982A (ja) 1986-11-07
GB8609532D0 (en) 1986-05-21
PT82423A (en) 1986-05-01
NZ215881A (en) 1989-01-06
FI84352B (fi) 1991-08-15
BE904619A (fr) 1986-08-18
ZA862937B (en) 1986-12-30
FI861656A0 (fi) 1986-04-18
PT82423B (pt) 1988-03-03
GB2174092A (en) 1986-10-29

Similar Documents

Publication Publication Date Title
US5120727A (en) Rapamycin dimers
US4225591A (en) 2,6-Diaminonebularines
BG64213B1 (bg) Глюкокортикоидселективни противовъзпалителни средства
EP0306408B1 (fr) Imidazo[1,2b]pyridazines, procédé pour leur préparation et compositions pharmaceutiques les contenant
US5036055A (en) Acylated derivatives of etoposide
US4863926A (en) Nitro aliphatic compounds, process for preparation thereof and use thereof
US4113873A (en) 8-azaprostanoic acid derivatives
US4256886A (en) Process for the preparation of oxadiazolopyrimidine derivatives
US4882316A (en) Pyrimidine derivatives
CS256397B2 (en) Method of new pyridylmethylthiothieno-(2,3-d)imidazole derivatives production
CS257791B2 (en) Method of eburnamenine's racemic and optically active derivatives' transstereoisomers production
EP0427606B1 (fr) Dérivés d'amidino-4 chromanne et d'amidino-4 pyranno (3,2-c) pyridine, procédé d'obtention et compositions pharmaceutiques les contenant
KR900005470B1 (ko) 피리딜알킬 나이트 레이트 화합물의 제조방법
US4180666A (en) 3,9-Dihydro-3,9-dioxo-2H-indeno(2,1-c)-pyridine-4-(carbonitriles/carboxamides)
CA1199638A (en) Eburnane-oxime ethers, process for their preparation and pharmaceutical compositions containing them
US3459764A (en) Preparation of nitroimidazole carbamates
PL135814B1 (en) Process for preparing novel bocyclic compounds
HU181496B (en) Process for preparing 10-bromo-15-hydroxy-e-homo-eburnanes
US5578596A (en) 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivatives, and production method and use thereof
KR840001034B1 (ko) 디하이드로니코틴산 유도체의 제조방법
EP0170926B1 (de) In der 9- oder 11-Stellung eine, gegebenenfalls substituierte, Aminogruppe aufweisende Eburnancarbonsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5202443A (en) Process for preparing 1-(2s)-3-mercapto-methyl-1-oxopropyl)-l-proline
CS255889B2 (en) Process for preparing new racemic and optical active derivatives of 9-and 11-aminoeburnancarboxylic acid
EP0125106B1 (en) 1-acylamino-1-cyclopentanecarboxylic acids and a process for preparing them
US5171857A (en) Antihypertensive benzopyran derivatives